Position in ARDX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$16,319,999
+$9,615,500 QoQ
Shares Held
3,200,000
+178.3% QoQ
Ownership
1.28%
of shares outstanding
% of Portfolio
1.48%
of 13F equity value
Holder Rank
#13
of 248 holders
Holding Since
Dec 2021
7 quarters on record
Voting authority
Sole 76%
Shared 24%
None 0%
Common Shares in ARDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AIGH Capital Management LLC holds $149,698,985 across 14 Biotechnology names. ARDX ranks #4 (10.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | FENC |
Fennec Pharmaceuticals Inc.
|
2,486,038 | $26,724,908 | |
| 2 | KYTX |
Kyverna Therapeutics, Inc.
|
2,795,797 | $24,910,550 | |
| 3 | ABEO |
Abeona Therapeutics Inc.
|
2,987,000 | $18,459,660 | |
| 4 | ARDX |
Ardelyx, Inc.
This page
|
3,200,000 | $16,319,999 | |
| 5 | SPRB |
Spruce Biosciences, Inc.
|
250,000 | $13,500,000 | |
| 6 | VNDA |
Vanda Pharmaceuticals Inc.
|
2,044,169 | $12,510,313 | |
| 7 | PTHS |
Pelthos Therapeutics Inc.
|
329,098 | $9,300,309 | |
| 8 | PYPD |
PolyPid Ltd.
|
1,504,741 | $7,644,084 |
All Filings in ARDX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,319,999 | 3,200,000 | Shares | Other | 2026-08-07 | |
| 2025-12-31 | $6,704,499 | 1,150,000 | Shares | Other | 2026-02-02 | |
| 2025-09-30 | $1,093,734 | 198,500 | Shares | Other | 2025-10-31 | |
| 2022-09-30 | $1,770,096 | 1,487,476 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $2,226,317 | 3,773,421 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,332,623 | 3,114,602 | Shares | Other | 2022-05-12 | |
| 2021-12-31 | $2,641,987 | 2,401,807 | Shares | Sole | 2022-02-10 | |
| No filing history on record for this holder in this stock. | ||||||